Literature DB >> 6467330

Cultured human tumour cells may be arrested in all stages of the cycle during stationary phase: demonstration of quiescent cells in G1, S and G2 phase.

B Drewinko, L Y Yang, B Barlogie, J M Trujillo.   

Abstract

Six human colon carcinoma cell lines were induced to enter stationary phase of growth by nutrient deprivation and cell crowding. Growth kinetics parameters (cell number, flow cytometric analysis of DNA distribution, and labelling and mitotic indices) were measured sequentially for all lines during the various stages of in vitro growth. Our results demonstrated that a substantial fraction of cells (9-18%) were located in G2 phase when they changed from an exponential to a stationary mode of growth. Moreover, a large number of cells in stationary phase of growth had an S-phase DNA content, as determined by flow cytometry, but failed to incorporate radioactive DNA precursors (up to 15-fold difference). To substantiate these findings, cells in stationary phase of growth were induced to enter exponential growth by re-seeding in fresh medium at a lower density. Subsequently observed changes in DNA-compartment distribution, and in labelling and mitotic indices were those expected from cells that had been arrested at different stages of the cycle during their previous stationary phase. Thus, the non-proliferating quiescent state (Q), traditionally located 'somewhere' in G1 phase, appears to be composed also of cells that can be arrested at other stages of the cycle (Qs and QG2). Although the proportion of such cells is rather small, their contribution to the growth kinetics behaviour of human in vivo tumours will become apparent following 'recruiting' or 'synchronizing' clinical manoeuvres and will prevent the formation of a clear-cut wave of synchronized cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467330     DOI: 10.1111/j.1365-2184.1984.tb00604.x

Source DB:  PubMed          Journal:  Cell Tissue Kinet        ISSN: 0008-8730


  9 in total

Review 1.  The plant cell cycle in context.

Authors:  M R Fowler; S Eyre; N W Scott; A Slater; M C Elliott
Journal:  Mol Biotechnol       Date:  1998-10       Impact factor: 2.695

Review 2.  Cellular quiescence in budding yeast.

Authors:  Siyu Sun; David Gresham
Journal:  Yeast       Date:  2021-01-25       Impact factor: 3.239

3.  Proliferation/Quiescence: When to start? Where to stop? What to stock?

Authors:  Bertrand Daignan-Fornier; Isabelle Sagot
Journal:  Cell Div       Date:  2011-12-09       Impact factor: 5.130

4.  Tumor cell recruitment in the mouse adenocarcinoma EO 771 directly demonstrated by double labeling with [3H]- and [14C] thymidine and flow cytometry.

Authors:  J Walter; B Maurer-Schultze
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  The Ki-67 antigen in primary human melanomas--its relationship to mitotic rate and tumor thickness and its stability.

Authors:  H Ostmeier; L Suter
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

6.  Persistence to anti-cancer treatments in the stationary to proliferating transition.

Authors:  Sivan Pearl Mizrahi; Orit Gefen; Itamar Simon; Nathalie Q Balaban
Journal:  Cell Cycle       Date:  2016-11-01       Impact factor: 4.534

7.  An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers.

Authors:  M S Wilson; C M West; G D Wilson; S A Roberts; R D James; P F Schofield
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

8.  Expression of DNA polymerase alpha and Leu3a molecules in growing and saturated cultures of human leukemic cells: phenotype analysis of proliferative cells by flow cytometry.

Authors:  M Shibata; Y Hirono; M Takahashi; T Kaneda
Journal:  Jpn J Cancer Res       Date:  1989-11

Review 9.  Quiescence Entry, Maintenance, and Exit in Adult Stem Cells.

Authors:  Karamat Mohammad; Paméla Dakik; Younes Medkour; Darya Mitrofanova; Vladimir I Titorenko
Journal:  Int J Mol Sci       Date:  2019-05-01       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.